BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26053711)

  • 21. Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases.
    Signorelli M; Guerra L; Buda A; Picchio M; Mangili G; Dell'Anna T; Sironi S; Messa C
    Gynecol Oncol; 2009 Nov; 115(2):231-5. PubMed ID: 19695685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
    Husby JA; Reitan BC; Biermann M; Trovik J; Bjørge L; Magnussen IJ; Salvesen ØO; Salvesen HB; Haldorsen IS
    J Nucl Med; 2015 Aug; 56(8):1191-8. PubMed ID: 26045311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complementary role of 18F-FDG PET/CT for sentinel lymph node algorithm in endometrial cancer with high-risk factors for lymphatic metastasis.
    Taşkin S; Varli B; Ersöz CC; Altin D; Soydal Ç; Ortaç F
    Nucl Med Commun; 2020 Apr; 41(4):389-394. PubMed ID: 31939903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isthmocervical labelling and SPECT/CT for optimized sentinel detection in endometrial cancer: technique, experience and results.
    Mücke J; Klapdor R; Schneider M; Länger F; Gratz KF; Hillemanns P; Hertel H
    Gynecol Oncol; 2014 Aug; 134(2):287-92. PubMed ID: 24823647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrospective validation of the laparoscopic ICG SLN mapping in patients with grade 3 endometrial cancer.
    Papadia A; Gasparri ML; Radan AP; Stämpfli CAL; Rau TT; Mueller MD
    J Cancer Res Clin Oncol; 2018 Jul; 144(7):1385-1393. PubMed ID: 29691646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sentinel-node mapping in endometrial cancer patients: comparing SPECT/CT, gamma-probe and dye.
    Elisei F; Crivellaro C; Giuliani D; Dolci C; De Ponti E; Montanelli L; La Manna M; Guerra L; Arosio M; Landoni C; Buda A
    Ann Nucl Med; 2017 Jan; 31(1):93-99. PubMed ID: 27815812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Sentinel Lymph Node Biopsy in Endometrial Cancer Patients: A Prospective Study.
    Palaia I; Di Donato V; Musella A; Di Pinto A; Santangelo G; Petriglia G; Benedetti Panici P
    J Invest Surg; 2021 Jun; 34(6):672-676. PubMed ID: 31647346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Utility of Sentinel Lymph Node Mapping in High-Grade Endometrial Cancer.
    Tanner EJ; Ojalvo L; Stone RL; Levinson K; Temkin SM; Murdock T; Vang R; Sinno AK; Fader AN
    Int J Gynecol Cancer; 2017 Sep; 27(7):1416-1421. PubMed ID: 30814241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sentinel Lymph Node Mapping in Endometrial Cancer: An Update.
    Khoury-Collado F; St Clair C; Abu-Rustum NR
    Oncologist; 2016 Apr; 21(4):461-6. PubMed ID: 26961924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
    Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
    BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sentinel lymph node biopsy in endometrial cancer-Feasibility, safety and lymphatic complications.
    Geppert B; Lönnerfors C; Bollino M; Persson J
    Gynecol Oncol; 2018 Mar; 148(3):491-498. PubMed ID: 29273307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO).
    Ballester M; Dubernard G; Lécuru F; Heitz D; Mathevet P; Marret H; Querleu D; Golfier F; Leblanc E; Rouzier R; Daraï E
    Lancet Oncol; 2011 May; 12(5):469-76. PubMed ID: 21489874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sentinel lymph node biopsy in high-grade endometrial cancer: a systematic review and meta-analysis of performance characteristics.
    Marchocki Z; Cusimano MC; Clarfield L; Kim SR; Fazelzad R; Espin-Garcia O; Bouchard-Fortier G; Rossi EC; Stewart KI; Soliman PT; How JA; Gotlieb WH; Holloway RW; Ianieri MM; Cabrera S; Lim YK; Ferguson SE
    Am J Obstet Gynecol; 2021 Oct; 225(4):367.e1-367.e39. PubMed ID: 34058168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of sentinel lymph node (SLN) mapping in high-risk endometrial cancer.
    Touhami O; Grégoire J; Renaud MC; Sebastianelli A; Plante M
    Gynecol Oncol; 2017 Dec; 147(3):549-553. PubMed ID: 28942993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sentinel Lymph Node Biopsy in Endometrial Cancer--Comparison of 2 Detection Methods.
    Sawicki S; Lass P; Wydra D
    Int J Gynecol Cancer; 2015 Jul; 25(6):1044-50. PubMed ID: 25853384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer.
    Salvo G; Ramirez PT; Levenback CF; Munsell MF; Euscher ED; Soliman PT; Frumovitz M
    Gynecol Oncol; 2017 Apr; 145(1):96-101. PubMed ID: 28188015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of sentinel lymph node metastases in apparent early-stage endometrial cancer: a multicenter observational study.
    De Vitis LA; Fumagalli D; Schivardi G; Capasso I; Grcevich L; Multinu F; Cucinella G; Occhiali T; Betella I; Guillot BE; Pappalettera G; Shahi M; Fought AJ; McGree M; Reynolds E; Colombo N; Zanagnolo V; Aletti G; Langstraat C; Mariani A; Glaser G
    Int J Gynecol Cancer; 2024 May; 34(5):689-696. PubMed ID: 38514100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integration of hybrid single-photon emission computed tomography/computed tomography in the preoperative assessment of sentinel node in patients with cervical and endometrial cancer: our experience and literature review.
    Buda A; Elisei F; Arosio M; Dolci C; Signorelli M; Perego P; Giuliani D; Recalcati D; Cattoretti G; Milani R; Messa C
    Int J Gynecol Cancer; 2012 Jun; 22(5):830-5. PubMed ID: 22617479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The incidence and clinical significance of the micrometastases in the sentinel lymph nodes during surgical staging for early endometrial cancer.
    Ferraioli D; Chopin N; Beurrier F; Carrabin N; Buenerd A; Mathevet P
    Int J Gynecol Cancer; 2015 May; 25(4):673-80. PubMed ID: 25902281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sentinel lymph node detection following the hysteroscopic peritumoural injection of 99mTc-labelled albumin nanocolloid in endometrial cancer.
    Maccauro M; Lucignani G; Aliberti G; Villano C; Castellani MR; Solima E; Bombardieri E
    Eur J Nucl Med Mol Imaging; 2005 May; 32(5):569-74. PubMed ID: 15625604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.